167 related articles for article (PubMed ID: 2465158)
21. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
Jurkowska G; Grondin G; Morisset J
Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
[TBL] [Abstract][Full Text] [Related]
22. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
[TBL] [Abstract][Full Text] [Related]
23. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
Reidelberger RD; O'Rourke MF
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1512-8. PubMed ID: 2481407
[TBL] [Abstract][Full Text] [Related]
24. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
Sundaram S; Dayan AD
Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
[TBL] [Abstract][Full Text] [Related]
25. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
26. Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice.
Ohshio G; Saluja A; Leli U; Sengupta A; Steer ML
Pancreas; 1989; 4(6):739-43. PubMed ID: 2813332
[TBL] [Abstract][Full Text] [Related]
27. Effect of L364718, a new CCK antagonist, on amylase secretion in isolated rat pancreatic acini.
Hosotani R; Chowdhury P; McKay D; Rayford PL
Pancreas; 1988; 3(1):95-8. PubMed ID: 2452436
[TBL] [Abstract][Full Text] [Related]
28. Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats.
Tachibana I; Shirohara H; Czako L; Akiyama T; Nakano S; Watanabe N; Hirohata Y; Otsuki M
Pancreas; 1997 Mar; 14(2):113-21. PubMed ID: 9057182
[TBL] [Abstract][Full Text] [Related]
29. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
Anderson L; Dockray GJ
Eur J Pharmacol; 1988 Feb; 146(2-3):307-11. PubMed ID: 3371402
[TBL] [Abstract][Full Text] [Related]
30. Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models.
Tani S; Okabayashi Y; Nakamura T; Fujii M; Itoh H; Otsuki M
Pancreas; 1990 May; 5(3):284-90. PubMed ID: 2343042
[TBL] [Abstract][Full Text] [Related]
31. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
[TBL] [Abstract][Full Text] [Related]
32. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin antagonist L364,718 induces alterations in acinar cells that prevent improvement of acute pancreatitis induced by obstruction.
De Dios I; Uruñuela A; Orfao A; Manso MA
Dig Dis Sci; 2002 Aug; 47(8):1800-9. PubMed ID: 12184533
[TBL] [Abstract][Full Text] [Related]
34. Time-course changes in pancreatic laboratory and morphologic parameters in two different acute pancreatitis models in rats.
Takács T; Czakó L; Jármay K; Hegyi P; Pozsár J; Marosi E; Pap A; Lonovics J
Acta Med Hung; 1994; 50(1-2):117-30. PubMed ID: 7543670
[TBL] [Abstract][Full Text] [Related]
35. Effect of FK480, a CCK-A receptor antagonist, on spontaneously developed chronic pancreatitis in WBN/Kob rats.
Ito H; Sogabe H; Kuno M; Satoh Y; Ogawa T; Konishi K; Yoshida K
Pancreas; 1998 Oct; 17(3):295-300. PubMed ID: 9788545
[TBL] [Abstract][Full Text] [Related]
36. Effect of long-term CCK blockade on the pancreatic acinar cell renewal in rats with acute pancreatitis.
de la Mano AM; Sevillano S; Manso MA; de Dios I
Peptides; 2003 Apr; 24(4):535-41. PubMed ID: 12860197
[TBL] [Abstract][Full Text] [Related]
37. Low enzyme content in the pancreas does not reduce the severity of acute pancreatitis induced by bile-pancreatic duct obstruction.
De La Mano A; Sevillano S; De Dios I; Vicente S; Manso MA
Mol Cell Biochem; 2002 Nov; 240(1-2):75-81. PubMed ID: 12487374
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor.
Rosewicz S; Lewis LD; Wang XY; Liddle RA; Logsdon CD
Am J Physiol; 1989 Apr; 256(4 Pt 1):G733-8. PubMed ID: 2468294
[TBL] [Abstract][Full Text] [Related]
39. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
[TBL] [Abstract][Full Text] [Related]
40. A cholecystokinin-releasing factor mediates ethanol-induced stimulation of rat pancreatic secretion.
Saluja AK; Lu L; Yamaguchi Y; Hofbauer B; Rünzi M; Dawra R; Bhatia M; Steer ML
J Clin Invest; 1997 Feb; 99(3):506-12. PubMed ID: 9022085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
